Question for Mr Ohm: Excuse my bio ignorance, b
Post# of 148155
Excuse my bio ignorance, but I have a broad cancer question. Namely -
Since cancer.gov defines cancer as "a disease in which some of the body’s cells grow uncontrollably and spread to other parts of the body" -
and since leronlimab's MOA interrupts the CCR5 link (among other things) that allows cancer cells to propagate -
then how come leronlimab seems to be viable against some cancers, but not all?
In other words, if cancer is cancer, then how come leronlimab's MOA isn't a silver bullet - silver M61 Vulcan cannon - against all cancers?